Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2018 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial

  • Authors:
    • Ahmed F. Elsaid
    • Magda Shaheen
    • Mamdooh Ghoneum
  • View Affiliations / Copyright

    Affiliations: Department of Community Medicine and Public Health, Faculty of Medicine, Zagazig University, Zagazig, Al Sharqia 44519, Egypt, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA, Department of Surgery, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
    Copyright: © Elsaid et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2313-2320
    |
    Published online on: January 8, 2018
       https://doi.org/10.3892/etm.2018.5713
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Aging is associated with a decline in natural killer (NK) and natural killer T (NKT) cell function that may contribute to increased susceptibility to malignancy and infection. A preliminary investigation was conducted examining the hypothesis that arabinoxylan rice bran (Biobran/MGN‑3), a denatured hemicellulose with known immunomodulatory activity, could counteract this decline in NK/NKT cell activity in geriatrics. A total of 12 healthy geriatric subjects of both sexes and over 56 years old, participated in a randomized, double‑blind, placebo‑controlled clinical trial. A total of six subjects served as control and six subjects ingested Biobran/MGN‑3 (500 mg/day) for 30 days. The effect of Biobran/MGN‑3 supplementation on NK/NKT cell activity was assessed using the degranulation assay. All study subjects were monitored for the development of any inadvertent side effects. In addition, the pharmacological effects of Biobran/MGN‑3 on blood cell components and liver and kidney functions were also assessed. Results demonstrated that Biobran/MGN‑3 had no effect on the total percentage of NK cells, however it enhanced the cytotoxic activity of induced NK cell expression of cluster of differentiation 107a, when compared with baseline values and with the placebo group (P<0.05). Furthermore, there were no side effects observed, indicating that Biobran/MGN‑3 supplementation was safe at the utilized dosage and for the duration of administration. Various additional beneficial effects were observed, including improved mean corpuscular volume and reduced hepatic aspartate aminotransferase enzyme levels, which suggested improved liver function. It was concluded that Biobran/MGN‑3 induces a significant increase in NK activity which may increase resistance to viral infections and cancers in the geriatric population. However, additional clinical trials should be conducted in the future to verify these findings.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Garza A: The Aging Population: The Increasing Effects on Health Care. http://www.pharmacytimes.com/publications/issue/2016/january2016/the-aging-population-the-increasing-effects-on-health-careJanuary 19–2016

2 

Alzheimer's Association, . 2017 Alzheimer's Disease Facts and Figures. http://www.alz.org/facts/August 18–2017

3 

American Cancer Society Cancer Action Network, . The Costs of Cancer. Addressing Patient Costs. https://www.acscan.org/sites/default/files/Costs%20of%20Cancer%20-%20Final%20Web.pdfAugust 18–2017

4 

Boulanger LM: Immune proteins in brain development and synaptic plasticity. Neuron. 64:93–109. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Nisticò R, Salter E, Nicolas C, Feligioni M, Mango D, Bortolotto ZA, Gressens P, Collingridge GL and Peineau S: Synaptoimmunology-roles in health and disease. Mol Brain. 10:262017. View Article : Google Scholar : PubMed/NCBI

6 

Gomez CR, Nomellini V, Faunce DE and Kovacs EJ: Innate immunity and aging. Exp Gerontol. 43:718–728. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Zanussi S, Serraino D, Dolcetti R, Berretta M and De Paoli P: Cancer, aging and immune reconstitution. Anticancer Agents Med Chem. 13:1310–1324. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R and Solana R: Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 82:50–55. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Ma Y and Fang M: Immunosenescence and age-related viral diseases. Sci China Life Sci. 56:399–405. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Lotzová E, Savary CA, Freedman RS and Bowen JM: Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract. Cancer Immunol Immunother. 17:124–129. 1984. View Article : Google Scholar : PubMed/NCBI

11 

Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R and Moretta A: Human natural killer cells: Their origin, receptors and function. Eur J Immunol. 32:1205–1211. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Chretien AS, Le Roy A, Vey N, Prebet T, Blaise D, Fauriat C and Olive D: Cancer-induced alterations of NK-mediated target recognition: Current and investigational pharmacological strategies aiming at restoring NK-mediated anti-tumor activity. Front Immunol. 5:1222014. View Article : Google Scholar : PubMed/NCBI

13 

Ivarsson MA, Michaëlsson J and Fauriat C: Activating killer cell Ig-like receptors in health and disease. Front Immunol. 5:1842014. View Article : Google Scholar : PubMed/NCBI

14 

Ghoneum M: Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochem Biophys Res Commun. 243:25–29. 1998. View Article : Google Scholar : PubMed/NCBI

15 

Ghoneum M and Jewett A: Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev. 24:314–324. 2000.PubMed/NCBI

16 

Ghoneum M and Gollapudi S: Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Lett. 201:41–49. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Badr El-Din NK, Noaman E and Ghoneum M: In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutr Cancer. 60:235–244. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Ghoneum M and Agrawal S: Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). Int J Immunopathol Pharmacol. 24:941–948. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, Mistrik M and Sedlak J: MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol Immunother. 62:437–445. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Ghoneum M, Badr El-Din NK, Ali DA and El-Dein MA: Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro. Anticancer Res. 34:81–87. 2014.PubMed/NCBI

21 

Ghoneum M: Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3). Int J Immunothe. 14:89–99. 1998.

22 

Alter G, Malenfant JM and Altfeld M: CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 294:15–22. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Ooi SL, McMullen D, Golombick T, Nut D and Pak SC: Evidence-based review of BioBran/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment. Integr Cancer Ther. Oct 1–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

24 

Ghoneum M and Brown J: NK immunorestoration of cancer patients by MGN-3, a modified arabinoxylan rice bran (study of 32 patients followed for up to 4 years)Wheat and rice in disease prevention and health. Anti-aging medical therapeutics. Klatz R and Goldman R: III. Health Quest Publications; Marina del Rey, CA: pp. 217–226. 1999

25 

Ghoneum M and Abedi S: Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol. 56:1581–1588. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Pérez-Martínez A, Valentín J, Fernández L, Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz F, Martín IG, Sallis H, et al: Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo. Cytotherapy. 17:601–612. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Ghoneum M: From bench to bedside: The growing use of arabinoxylan rice bran (MGN-3/Biobran) in cancer immunotherapy. Austin Immunol. 1:10062016.

28 

Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, Minami S and Dan K: Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol. 124:392–397. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Smetana K Jr, Lacina L, Szabo P, Dvořánková B, Brož P and Šedo A: Ageing as an important risk factor for cancer. Anticancer Res. 36:5009–5017. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Ghoneum M, Suzuki K and Gollapudi S: Phorbol myristate acetate corrects impaired NK function of old mice. Scand J Immunol. 34:391–397. 1991. View Article : Google Scholar : PubMed/NCBI

31 

Mariani E, Sgobbi S, Meneghetti A, Tadolini M, Tarozzi A, Sinoppi M, Cattini L and Facchini A: Perforins in human cytolytic cells: The effect of age. Mech Ageing Dev. 92:195–209. 1996. View Article : Google Scholar : PubMed/NCBI

32 

Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, Christmas SE and Podack ER: Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood. 92:2410–2420. 1998.PubMed/NCBI

33 

Chng WJ, Tan GB and Kuperan P: Establishment of adult peripheral blood lymphocyte subset reference range for an asian population by single-platform flow cytometry: Influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol. 11:168–173. 2004.PubMed/NCBI

34 

Wang WS, Lo AW, Siu LP, Leung JN, Tu SP, Tai SW, Lam SC and Wong KF: Reference ranges for lymphocyte subsets among healthy Hong Kong Chinese adults by single-platform flow cytometry. Clin Vaccine Immunol. 20:602–606. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Al-Mawali A, Pinto AD, Busaidi RA and Al-Zakwani I: Lymphocyte subsets: Reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry A. 83:739–744. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Krzewski K, Gil-Krzewska A, Nguyen V, Peruzzi G and Coligan JE: LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood. 121:4672–4683. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Aktas E, Kucuksezer UC, Bilgic S, Erten G and Deniz G: Relationship between CD107a expression and cytotoxic activity. Cell Immunol. 254:149–154. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Sun JC and Lanier LL: Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 39:2059–2064. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ and Baxter AG: NKT cells: Facts, functions and fallacies. Immunol Today. 21:573–583. 2000. View Article : Google Scholar : PubMed/NCBI

40 

Brigl M and Brenner MB: CD1: Antigen presentation and T cell function. Annu Rev Immunol. 22:817–890. 2004. View Article : Google Scholar : PubMed/NCBI

41 

Shin JH and Park SH: The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells. BMB Rep. 47:241–248. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Nisticò R, Pignatelli M, Piccinin S, Mercuri NB and Collingridge G: Targeting synaptic dysfunction in Alzheimer's disease therapy. Mol Neurobiol. 46:572–587. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Pignatelli M, Feligioni M, Piccinin S, Molinaro G, Nicoletti F and Nisticò R: Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders. Curr Pharm Des. 19:6480–6490. 2013. View Article : Google Scholar : PubMed/NCBI

44 

Nisticò R, Mori F, Feligioni M, Nicoletti F and Centonze D: Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Philos Trans R Soc Lond Ser B Biol Sci. 369:201301622013. View Article : Google Scholar

45 

Musumeci G, Castrogiovanni P, Szychlinska MA, Imbesi R, Loreto C, Castorina S and Giunta S: Protective effects of high Tryptophan diet on aging-induced passive avoidance impairment and hippocampal apoptosis. Brain Res Bull. 128:76–82. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW and Arancio O: Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J Neurosci. 29:8075–8086. 2009. View Article : Google Scholar : PubMed/NCBI

47 

Salama H, Medhat E, Shaheen M, Zekri AN, Darwish T and Ghoneum M: Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial. Int J Immunopathol Pharmacol. 29:647–653. 2016. View Article : Google Scholar : PubMed/NCBI

48 

Daiwa Pharmaceutical and Co., Ltd., . BioBran rice bran arabinoxylan compound. http://www.daiwa-pharm.com/english/product/biobran.htmlOctober 22–2017

49 

Tazawa K: BioBran/MGN-3: Basic and Clinical Application to Integrative Medicine. Iyakushuppan Co. Publishers; Tokyo: pp. 18–22. 2003

50 

Takahara K and Sano K: The life prolongation and QOL improvement effect of rice bran arabinoxylan derivative (MGN-3, Bio-Bran) for progressive cancer. Clin Pharmacol Therapy. 14:267–271. 2004.

51 

Hajto T, Horvath A and Papp S: Improvement of quality of life in tumor patients after an immunomodulatory treatment with standardized mistletoe lectin and arabinoxylan plant extracts. Int J Neurorehabilitation. 3:1–3. 2016. View Article : Google Scholar

52 

Shimotoyodome A, Suzuki J, Kameo Y and Hase T: Dietary supplementation with hydroxypropyl-distarch phosphate from waxy maize starch increases resting energy expenditure by lowering the postprandial glucose-dependent insulinotropic polypeptide response in human subjects. Br J Nutr. 106:96–104. 2011. View Article : Google Scholar : PubMed/NCBI

53 

Hood LF, Vancampen DR, House WA and Szatkowski E: Effect of modified and unmodified tapioca starches on 59Fe retention in rats. J Nutr. 106:1768–1772. 1976. View Article : Google Scholar : PubMed/NCBI

54 

Kishida T, Nakai Y and Ebihara K: Hydroxypropyl-distarch phosphate from Tapioca starch reduces zinc and iron absorption, but not calcium and magnesium absorption, in rats. J Nutr. 131:294–300. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Elsaid AF, Shaheen M and Ghoneum M: Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial. Exp Ther Med 15: 2313-2320, 2018.
APA
Elsaid, A.F., Shaheen, M., & Ghoneum, M. (2018). Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial. Experimental and Therapeutic Medicine, 15, 2313-2320. https://doi.org/10.3892/etm.2018.5713
MLA
Elsaid, A. F., Shaheen, M., Ghoneum, M."Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial". Experimental and Therapeutic Medicine 15.3 (2018): 2313-2320.
Chicago
Elsaid, A. F., Shaheen, M., Ghoneum, M."Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial". Experimental and Therapeutic Medicine 15, no. 3 (2018): 2313-2320. https://doi.org/10.3892/etm.2018.5713
Copy and paste a formatted citation
x
Spandidos Publications style
Elsaid AF, Shaheen M and Ghoneum M: Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial. Exp Ther Med 15: 2313-2320, 2018.
APA
Elsaid, A.F., Shaheen, M., & Ghoneum, M. (2018). Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial. Experimental and Therapeutic Medicine, 15, 2313-2320. https://doi.org/10.3892/etm.2018.5713
MLA
Elsaid, A. F., Shaheen, M., Ghoneum, M."Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial". Experimental and Therapeutic Medicine 15.3 (2018): 2313-2320.
Chicago
Elsaid, A. F., Shaheen, M., Ghoneum, M."Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial". Experimental and Therapeutic Medicine 15, no. 3 (2018): 2313-2320. https://doi.org/10.3892/etm.2018.5713
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team